Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Mycophenolate Mofetil products are in shortage in Canada (4 of 16 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An immunosuppressant used to help prevent rejection of a transplanted organ.
Products affected
4 / 16
In shortage since
Dec 5, 2023
Reports on file
71
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TEVA-MYCOPHENOLATE
250MG · CAPSULE · TEVA CANADA LIMITED
DIN 02364883 · since Jun 10, 2026, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP-MYCOPHENOLATE
500MG · TABLET · JAMP PHARMA CORPORATION
DIN 02380382 · since Aug 7, 2025, est. end Mar 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-MYCOPHENOLATE
500MG · TABLET · APOTEX INC
DIN 02352567 · since Dec 5, 2023, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-MYCOPHENOLATE
250MG · CAPSULE · APOTEX INC
DIN 02352559 · since Dec 5, 2023, no end estimate · Disruption of the manufacture of the drug.
Resolved
TEVA-MYCOPHENOLATE
500MG · TABLET · TEVA CANADA LIMITED
DIN 02348675 · ended May 31, 2026 · Disruption of the manufacture of the drug.
Resolved
ACH-MYCOPHENOLATE
250MG · CAPSULE · ACCORD HEALTHCARE INC
DIN 02383780 · ended Apr 1, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
ACH-MYCOPHENOLATE
500MG · TABLET · ACCORD HEALTHCARE INC
DIN 02378574 · ended Apr 1, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
SANDOZ MYCOPHENOLATE MOFETIL
500MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02313855 · ended Jan 30, 2026 · Disruption of the manufacture of the drug.
Resolved
MYCOPHENOLATE MOFETIL FOR INJECTION, USP
500MG · POWDER FOR SOLUTION · ACCORD HEALTHCARE INC
DIN 02444836 · ended Jan 30, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-MYCOPHENOLATE
500MG · TABLET · TEVA CANADA LIMITED
DIN 02348675 · ended Jan 7, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ MYCOPHENOLATE MOFETIL
500MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02313855 · ended Dec 12, 2025 · Delay in shipping of the drug.
Resolved
SANDOZ MYCOPHENOLATE MOFETIL
500MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02313855 · ended Oct 31, 2025 · Demand increase for the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Mycophenolate Mofetil is currently affected by 4 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, JAMP PHARMA CORPORATION, APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Mycophenolate Mofetil is classified under “IMMUNOSUPPRESSANTS” (ATC L04AA).
Recent changes
No changes recorded yet.
Common questions
What is Mycophenolate Mofetil used for?
An immunosuppressant used to help prevent rejection of a transplanted organ.
When will Mycophenolate Mofetil be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Mycophenolate Mofetil in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.